New COVID-19 vaccine research from the U.K. looks at “vaccine mixing” — receiving your first dose of the shot from one brand, and the second dose from a different one. In the study, participants received one shot of the Pfizer vaccine and one from AstraZeneca, which is not available in the U.S.
